Os Therapies Incorporated Stock Investor Sentiment

OSTX Stock   3.02  1.44  32.29%   
Slightly above 62% of OS Therapies' investor base is looking to short. The analysis of the overall investor sentiment regarding OS Therapies Incorporated suggests that many traders are alarmed. OS Therapies' investing sentiment can be driven by a variety of factors including economic data, OS Therapies' earnings reports, geopolitical events, and overall market trends.
  
over two weeks ago at thelincolnianonline.com         
OS Therapies Shares Up 5.1 percent Heres Why
news
over three weeks ago at news.google.com         
OS Therapies Incorporated Reports Earnings Results for the Third Quarter and Nine Months Ended Septe...
Google News at Macroaxis
over three weeks ago at seekingalpha.com         
OS Therapies reports Q3 results
seekingalpha News
over a month ago at news.google.com         
OS Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update - Yahoo Finan...
Google News at Macroaxis
over a month ago at seekingalpha.com         
OS Therapies files to sell 15M in common stock for holders
seekingalpha News
over a month ago at thelincolnianonline.com         
OS Therapies Enters into Equity Purchase Agreement with Square Gate Capital Master Fund, LLC-Series ...
news
over a month ago at www.macroaxis.com         
Insider Trading
Macroaxis News
over a month ago at www.macroaxis.com         
Insider Trading
Macroaxis News
over two months ago at news.google.com         
OS Therapies Trading Up 0.3 percent - MarketBeat
Google News at Macroaxis
over three months ago at www.macroaxis.com         
Acquisition by Ciccio John of 266306 shares of OS THERAPIES at 75000.0 subject to Rule 16b-3
Macroaxis News
over three months ago at www.macroaxis.com         
Acquisition by Search Theodore F. of 30264 shares of OS THERAPIES at 50000.0 subject to Rule 16b-3
Macroaxis News
over three months ago at news.google.com         
EF Hutton sets Buy rating for OS Therapies stock on cancer approach - Investing.com UK
Google News at Macroaxis
over three months ago at news.google.com         
OS Therapies Stock Quotes, Forecast and News Summary - Benzinga
Google News at Macroaxis
over three months ago at news.google.com         
OS Therapies Completes OST-HER2 Osteosarcoma Trial Dosing - Investing.com
Google News at Macroaxis
over three months ago at investorplace.com         
OSTX Stock Earnings OS Therapies Reported Results for Q2 2024
sbwire news
Far too much social signal, news, headlines, and media speculation about OS Therapies that are available to investors today. That information is available publicly through OSTX media outlets and privately through word of mouth or via OSTX internal channels. However, regardless of the origin, that massive amount of OSTX data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of OS Therapies news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of OS Therapies relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to OS Therapies' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive OS Therapies alpha.

OS Therapies Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Insider Trading
10/28/2024
2
OS Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update - Yahoo Finance
11/15/2024

Additional Tools for OSTX Stock Analysis

When running OS Therapies' price analysis, check to measure OS Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OS Therapies is operating at the current time. Most of OS Therapies' value examination focuses on studying past and present price action to predict the probability of OS Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OS Therapies' price. Additionally, you may evaluate how the addition of OS Therapies to your portfolios can decrease your overall portfolio volatility.